FDA to start naming names of pharma companies blocking cheaper generics

The Food and Drug Administration plans this week to effectively begin publicly shaming brand-name drug companies that stand in the way of competitors trying to develop cheaper generic drugs.

Read More

Image courtesy of: Beth Mole

Advertisements